
A new partnership between the Lundin Cancer Fund and Canadian Cancer Society is aiming to save and improve the lives of people facing glioblastoma — the most aggressive and deadly form of brain cancer. The Lundin Cancer Fund is contributing $4 million to the Canadian Cancer Society to establish Canada’s largest 5-year research program focused exclusively on glioblastoma: the Glioblastoma Research Program. The gift is the largest philanthropic contribution for glioblastoma research ever received by the Canadian Cancer Society.
Together, the organizations will also raise an additional $4 million, for a total of $8 million, to transform brain cancer outcomes. To support the project, and in memory of Lukas Lundin, two of Vancouver’s largest galas — the Canadian Cancer Society Daffodil Ball and the Lundin Cancer Fund Gala — will unite in 2025. Lukas Lundin, a visionary leader in the international mining sector, who passed away in 2022, two years after being diagnosed with glioblastoma.
“At the Lundin Cancer Fund, our mission is to finance the very best in cancer research worldwide,” explains Jack Lundin, CEO, Lundin Mining Corporation. “That’s why we’re thrilled to partner with the Canadian Cancer Society — the leading cancer charity in the country that is driving progress, innovation and impact in cancer research. We are confident that together we can spur action and change for people facing glioblastoma.”
On average, the 5-year survival rate for people facing brain cancer is 22% but for people facing glioblastoma, the prognosis is even more dire. The 5-year survival rate for glioblastoma is only 4.9%. On average, most people with glioblastoma are not expected to survive past the first year after diagnosis.
“Glioblastoma is a complex and devastating cancer with immense impact on people, their loved ones and communities. The stakes couldn’t be higher,” says Andrea Seale, CEO, Canadian Cancer Society. “With the generous contribution of the Lundin Cancer Fund, together with the support from our Daffodil Ball community, we have an unparalleled opportunity to achieve meaningful progress against glioblastoma.”
Source: BNNBLOOMBERG